XML 52 R4.htm IDEA: XBRL DOCUMENT v3.20.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Operating expenses:    
Research and development $ 51,878 $ 26,190
Selling, general and administrative 19,902 13,551
Total operating expenses 71,780 39,741
Loss from operations (71,780) (39,741)
Interest and other income, net 1,912 2,271
Net loss (69,868) (37,470)
Other comprehensive income 122 363
Comprehensive loss $ (69,746) $ (37,107)
Net loss per share, basic and diluted $ (1.50) $ (0.93)
Weighted average number of shares used to compute net loss per share, basic and diluted 46,566,995 40,506,313